Association between topical corticosteroid use and type 2 diabetes in two european population-based adult cohorts
Association between topical corticosteroid use and type 2 diabetes in two european population-based adult cohorts
OBJECTIVE Topical corticosteroids (CSs) are commonly used to treat inflammatory skin conditions including eczema and psoriasis. Although topical CS package inserts describe hyperglycemia and glycosuria as adverse drug reactions, it is unclear whether topical CS use in real life is also associated with an increased risk of type 2 diabetes (T2D).
RESEARCH DESIGN AND METHODS Two matched case-control studies and one cohort study were conducted using routinely collected health care data from Denmark and the U.K. A total of 115,218 and 54,944 adults were identified as case subjects with new-onset T2D in the Danish and U.K. case-control study, respectively. For the Danish cohort study, 2,689,473 adults were included. The main exposure was topical CSs, and the outcome was incident T2D. RESULTS Topical CS was significantly associated with T2D in the Danish (adjusted odds ratio [OR] 1.25 [95% CI 1.23?1.28]) and U.K. (adjusted OR 1.27 [95% CI 1.23?1.31]) case-control studies. Individuals who were exposed to topical CSs had significantly increased risk of incident T2D (adjusted hazard ratio 1.27 [95% CI 1.26?1.29]). We observed significant dose-response relationships between T2D and increasing potency of topical CSs in the two Danish studies. The results were consistent across all sensitivity analyses.
CONCLUSIONS We found a positive association between topical CS prescribing and incident T2D in Danish and U.K. adult populations. Clinicians should be cognizant of possible diabetogenic effects of potent topical CSs.
1095-1103
Andersen, Yuki M.F.
f1c3d8c0-1cba-49fe-93ca-0e68d0f24643
Egeberg, Alexander
0caa4f69-7767-479a-96fd-1d8125ae0e94
Ban, Lu
c4d642ed-a581-4acb-8ad9-52bf04f79ffb
Gran, Sonia
c1e36f79-0398-43f5-a93c-c3329fa3a23c
Williams, Hywel C.
3914e691-2348-4704-a044-e8d2af92444e
Francis, Nick A.
9b610883-605c-4fee-871d-defaa86ccf8e
Knop, Filip K.
a619b720-15a2-4527-b637-00ed42d667ad
Gislason, Gunnar H.
ff29422f-6c3f-47ea-9aa9-75d3b153fe21
Skov, Lone
42ec06b3-d256-4b64-9dc7-0a61df68e1af
Thyssen, Jacob P.
00c73b00-e707-42ec-9a80-5f3d003dea32
1 June 2019
Andersen, Yuki M.F.
f1c3d8c0-1cba-49fe-93ca-0e68d0f24643
Egeberg, Alexander
0caa4f69-7767-479a-96fd-1d8125ae0e94
Ban, Lu
c4d642ed-a581-4acb-8ad9-52bf04f79ffb
Gran, Sonia
c1e36f79-0398-43f5-a93c-c3329fa3a23c
Williams, Hywel C.
3914e691-2348-4704-a044-e8d2af92444e
Francis, Nick A.
9b610883-605c-4fee-871d-defaa86ccf8e
Knop, Filip K.
a619b720-15a2-4527-b637-00ed42d667ad
Gislason, Gunnar H.
ff29422f-6c3f-47ea-9aa9-75d3b153fe21
Skov, Lone
42ec06b3-d256-4b64-9dc7-0a61df68e1af
Thyssen, Jacob P.
00c73b00-e707-42ec-9a80-5f3d003dea32
Andersen, Yuki M.F., Egeberg, Alexander, Ban, Lu, Gran, Sonia, Williams, Hywel C., Francis, Nick A., Knop, Filip K., Gislason, Gunnar H., Skov, Lone and Thyssen, Jacob P.
(2019)
Association between topical corticosteroid use and type 2 diabetes in two european population-based adult cohorts.
Diabetes Care, 42 (6), .
(doi:10.2337/dc18-2158).
Abstract
OBJECTIVE Topical corticosteroids (CSs) are commonly used to treat inflammatory skin conditions including eczema and psoriasis. Although topical CS package inserts describe hyperglycemia and glycosuria as adverse drug reactions, it is unclear whether topical CS use in real life is also associated with an increased risk of type 2 diabetes (T2D).
RESEARCH DESIGN AND METHODS Two matched case-control studies and one cohort study were conducted using routinely collected health care data from Denmark and the U.K. A total of 115,218 and 54,944 adults were identified as case subjects with new-onset T2D in the Danish and U.K. case-control study, respectively. For the Danish cohort study, 2,689,473 adults were included. The main exposure was topical CSs, and the outcome was incident T2D. RESULTS Topical CS was significantly associated with T2D in the Danish (adjusted odds ratio [OR] 1.25 [95% CI 1.23?1.28]) and U.K. (adjusted OR 1.27 [95% CI 1.23?1.31]) case-control studies. Individuals who were exposed to topical CSs had significantly increased risk of incident T2D (adjusted hazard ratio 1.27 [95% CI 1.26?1.29]). We observed significant dose-response relationships between T2D and increasing potency of topical CSs in the two Danish studies. The results were consistent across all sensitivity analyses.
CONCLUSIONS We found a positive association between topical CS prescribing and incident T2D in Danish and U.K. adult populations. Clinicians should be cognizant of possible diabetogenic effects of potent topical CSs.
This record has no associated files available for download.
More information
Accepted/In Press date: 7 March 2019
e-pub ahead of print date: 1 April 2019
Published date: 1 June 2019
Identifiers
Local EPrints ID: 435521
URI: http://eprints.soton.ac.uk/id/eprint/435521
ISSN: 1935-5548
PURE UUID: 4f76b8bb-5c3e-4adb-9763-6bb101b5ca65
Catalogue record
Date deposited: 08 Nov 2019 17:30
Last modified: 17 Mar 2024 03:58
Export record
Altmetrics
Contributors
Author:
Yuki M.F. Andersen
Author:
Alexander Egeberg
Author:
Lu Ban
Author:
Sonia Gran
Author:
Hywel C. Williams
Author:
Filip K. Knop
Author:
Gunnar H. Gislason
Author:
Lone Skov
Author:
Jacob P. Thyssen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics